Dr. Paul Sax shares highlights from this year's International AIDS Conference, in
HIV and ID Observations.
In the latest HIV and ID Observations blog post, Dr. Paul Sax gives us his Really Rapid Review of the 2019 International AIDS Society Conference in Mexico City, including revised information about the safety of dolutegravir taken at the time of conception, a comparison of raltegravir- versus efavirenz-based treatment for HIV1-infected adults with tuberculosis, and satisfactory outcomes with injectable cabotegravir plus rilpivirine.
Want to see more from NEJM Journal Watch? Register here.